Pfizer (PFE)

42.18 +0.04 (0.09%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/1/19 *Est.)

Latest Headlines

ICON Reports Fourth Quarter and Full Year 2018 Results February 20, 2019 4:15 PM - BizWire Citi Resumes Pfizer (PFE) at Neutral February 19, 2019 4:27 PM - StreetInsider Ochsner Health System and Pfizer Partner to Develop Innovative Models for Clinical Trials February 19, 2019 10:30 AM - BizWire Pfizer (PFE) Receives European Approval for ZIRABEV, Biosimilar to Avastin February 19, 2019 9:33 AM - StreetInsider Pfizer Receives European Approval for ZIRABEV™ (bevacizumab), a Biosimilar to Avastin®* February 19, 2019 9:32 AM - BizWire UPDATE: Pfizer (PFE) to Provide $15M Milestone Payment to Gliknik Inc. Following Clinical Progress with PF-06755347, Previously Known As GL-2045 February 19, 2019 8:32 AM - StreetInsider Gliknik To Receive $15 Million Milestone Payment From Pfizer Inc. Following Clinical Progress With PF-06755347, Previously Known As GL-2045 February 19, 2019 8:30 AM - PR NewsWire Pfizer (PFE) and Lilly (LLY) Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain February 19, 2019 6:51 AM - StreetInsider Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain February 19, 2019 6:45 AM - PR NewsWire Merck (MRK) Reports Pivotal Phase III Data for BAVENCIO (avelumab) Plus INLYTA (axitinib) in Advanced RCC Published in New England Journal of Medicine (Earlier) February 19, 2019 5:54 AM - StreetInsider Pivotal Phase III Data for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine February 16, 2019 5:14 PM - PR NewsWire Form SC 13G PFIZER INC Filed by: STATE STREET CORP February 14, 2019 10:05 AM - SEC Filing Form 4 PFIZER INC For: Feb 11 Filed by: YOUNG JOHN D February 12, 2019 5:52 PM - SEC Filing Form 4 PFIZER INC For: Feb 11 Filed by: JOHNSON RADY A February 12, 2019 5:52 PM - SEC Filing Form 4 PFIZER INC For: Feb 11 Filed by: ROGERS DAWN February 12, 2019 5:52 PM - SEC Filing Form 4 PFIZER INC For: Feb 11 Filed by: BOURLA ALBERT February 12, 2019 5:52 PM - SEC Filing EMD Seron, Pfizer (PFE) Announce FDA Accepted sBLA and Granted Priority Review for BAVENCIO Plus INLYTA for Treatment of Advanced RCC February 11, 2019 5:45 PM - StreetInsider FDA Accepts sBLA and Grants Priority Review for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) for the Treatment of Advanced Renal Cell Carcinoma February 11, 2019 5:44 PM - PR NewsWire Bristol-Myers Squibb (BMY) Announces Opdivo Plus Low-Dose Yervoy Demonstrates Continued Survival Benefit at 30-Month Follow-up in Patients with Previously Untreated Advanced or Metastatic RCC February 11, 2019 5:05 PM - StreetInsider Pfizer Inc. (PFE) and Astellas Announce Phase 3 ARCHES Trial Shows XTANDI Significantly Improved Radiographic PFS in Men with Metastatic Hormone-Sensitive Prostate Cancer February 11, 2019 5:01 PM - StreetInsider Phase 3 ARCHES Trial Shows XTANDI® (enzalutamide) Significantly Improved Radiographic Progression-Free Survival in Men with Metastatic Hormone-Sensitive Prostate Cancer February 11, 2019 5:00 PM - BizWire Phase 3 ARCHES Trial Shows XTANDI® (enzalutamide) Significantly Improved Radiographic Progression-Free Survival in Men with Metastatic Hormone-Sensitive Prostate Cancer February 11, 2019 5:00 PM - PR NewsWire Form SC 13G/A PFIZER INC Filed by: VANGUARD GROUP INC February 11, 2019 2:48 PM - SEC Filing Form 4 PFIZER INC For: Feb 04 Filed by: DAMELIO FRANK A February 6, 2019 4:19 PM - SEC Filing Form SC 13G/A PFIZER INC Filed by: BlackRock Inc. February 6, 2019 3:10 PM - SEC Filing Pfizer (PFE) option implied volatility flat into President Trump State of Union Address February 4, 2019 6:12 AM - StreetInsider Form 4 PFIZER INC For: Jan 31 Filed by: Dolsten Mikael February 1, 2019 7:29 PM - SEC Filing Form 4 PFIZER INC For: Jan 30 Filed by: LANKLER DOUGLAS M February 1, 2019 7:22 PM - SEC Filing Pfizer (PFE) Reports Positive CHMP Opinion for Vizimpro (dacomitinib) Positive CHMP Opinion for Vizimpro (dacomitinib) for 1st-Line Treatment of Adult Patients February 1, 2019 9:21 AM - StreetInsider Pfizer Receives Positive CHMP Opinion for Vizimpro® (dacomitinib) for the First-line Treatment of Adult Patients with Locally Advanced Or Metastatic Non-Small Cell Lung Cancer with EGFR-Activating Mu February 1, 2019 9:17 AM - BizWire Pfizer (PFE) Risk/Reward Seems Favorable, But Not Enough for Upgrade - BMO January 31, 2019 12:21 PM - StreetInsider Argus Upgrades Pfizer (PFE) to Buy January 31, 2019 6:51 AM - StreetInsider Credit Suisse Upgrades Pfizer (PFE) to Outperform January 31, 2019 4:54 AM - StreetInsider Pfizer (PFE) PT Lowered to $45 at BofA/Merrill Lynch January 30, 2019 6:09 AM - StreetInsider Pfizer (PFE) Read-Through Positive for Eidos Therapeutics (EIDX) - Leerink January 29, 2019 2:51 PM - StreetInsider Pfizer (PFE) CEO: Currently Focused on Smaller Deals - Bloomberg January 29, 2019 10:23 AM - StreetInsider Pfizer (PFE) Sees Red-to-Green Reversal January 29, 2019 9:54 AM - StreetInsider Pre-Open Stock Movers 01/29: (SANM) (DDD) (WWD) Higher; (GME) (HOG) (RMBS) Lower (more...) January 29, 2019 9:16 AM - StreetInsider Form 8-K PFIZER INC For: Jan 29 January 29, 2019 8:50 AM - SEC Filing Pfizer (PFE) Tops Q4 EPS by 1c, FY EPS Guidance Misses Consensus January 29, 2019 6:46 AM - StreetInsider PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2018 RESULTS January 29, 2019 6:45 AM - BizWire Pfizer (PFE), Lilly (LLY) Announce Top-Line Results From Second Phase 3 Study of Tanezumab in Osteoarthritis Pain January 29, 2019 6:34 AM - StreetInsider Pfizer and Lilly Announce Top-Line Results From Second Phase 3 Study of Tanezumab in Osteoarthritis Pain January 29, 2019 6:30 AM - BizWire Pfizer (PFE) option implied volatility increases on more calls than puts into EPS January 28, 2019 5:37 AM - StreetInsider Pfizer (PFE) call put ratio 1.95 call to 1 put into Tuesday EPS January 25, 2019 10:46 AM - StreetInsider Pfizer (PFE) weekly option implied volatility bid dinto EPS January 25, 2019 5:36 AM - StreetInsider UBS Downgrades Pfizer (PFE) to Neutral January 23, 2019 5:41 AM - StreetInsider Exclusive: Private equity firms circling Nestle's skin health business - sources January 21, 2019 11:06 AM - StreetInsider GSK Chairman Hampton to step down ahead of split January 21, 2019 2:15 AM - StreetInsider Pfizer (PFE) call put ratio 2.1 calls to 1 put with focus on March 52.50 calls January 18, 2019 12:39 PM - StreetInsider Trump's attorney general nominee vows to shield Russia probe from politics January 14, 2019 10:36 AM - StreetInsider Pfizer (PFE) Reports FDA Accepts Regulatory Submissions for Review of Tafamidis to Treat Transthyretin Amyloid Cardiomyopathy January 14, 2019 8:05 AM - StreetInsider US FDA Accepts Regulatory Submissions for Review of Tafamidis to Treat Transthyretin Amyloid Cardiomyopathy January 14, 2019 8:00 AM - BizWire Form 4 PFIZER INC For: Jan 10 Filed by: ROGERS DAWN January 11, 2019 6:21 PM - SEC Filing Form 4 PFIZER INC For: Jan 10 Filed by: YOUNG JOHN D January 11, 2019 6:21 PM - SEC Filing Form 4 PFIZER INC For: Jan 10 Filed by: JOHNSON RADY A January 11, 2019 6:21 PM - SEC Filing Form 4 PFIZER INC For: Jan 10 Filed by: BOURLA ALBERT January 11, 2019 6:21 PM - SEC Filing Form 3 PFIZER INC For: Jan 02 Filed by: Fonseca Lidia January 11, 2019 2:35 PM - SEC Filing Amarin Corp. (AMRN) Gains on Renewed Chatter January 10, 2019 10:28 AM - StreetInsider Pfizer to shut two manufacturing plants in India January 9, 2019 10:26 AM - StreetInsider Pfizer (PFE) Enters Collaboration Agreement with CytoReason January 7, 2019 8:06 AM - StreetInsider CytoReason Signs Collaboration Agreement with Pfizer Inc. To Utilize CytoReason’s Machine Learning Model of the Immune System for Drug Discovery January 7, 2019 8:00 AM - BizWire Pfizer (PFE) Begins Phase 2b/3 Clinical Trial for PF-06651600 for Treatment of Patients with Moderate to Severe Alopecia Areata January 3, 2019 8:40 AM - StreetInsider Pfizer Initiates Phase 2b/3 Clinical Trial for PF-06651600, an Oral JAK3 Inhibitor, for the Treatment of Patients with Moderate to Severe Alopecia Areata January 3, 2019 8:30 AM - BizWire Bristol-Myers to buy Celgene for $74 billion in largest biopharma deal January 3, 2019 7:06 AM - StreetInsider Form 4 PFIZER INC For: Dec 31 Filed by: KILTS JAMES M January 2, 2019 5:38 PM - SEC Filing Form 4 PFIZER INC For: Dec 27 Filed by: SUSMAN SALLY January 2, 2019 5:38 PM - SEC Filing Form 4 PFIZER INC For: Dec 31 Filed by: SMITH JAMES C January 2, 2019 5:38 PM - SEC Filing Form 4 PFIZER INC For: Dec 31 Filed by: YOUNG JOHN D January 2, 2019 5:38 PM - SEC Filing Form 4 PFIZER INC For: Dec 31 Filed by: NARAYEN SHANTANU January 2, 2019 5:38 PM - SEC Filing Form 4 PFIZER INC For: Dec 31 Filed by: Echevarria Joseph January 2, 2019 5:38 PM - SEC Filing Form 4 PFIZER INC For: Dec 31 Filed by: ROGERS DAWN January 2, 2019 5:38 PM - SEC Filing Form 4 PFIZER INC For: Dec 31 Filed by: JOHNSON RADY A January 2, 2019 5:37 PM - SEC Filing Form 4 PFIZER INC For: Dec 31 Filed by: BOURLA ALBERT January 2, 2019 5:37 PM - SEC Filing Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference December 31, 2018 10:00 AM - BizWire Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference December 27, 2018 10:00 AM - BizWire UPDATE: Merck KGaA, Pfizer (PFE) to Terminate JAVELIN Ovarian 100 Trial of Avelumab December 21, 2018 2:03 PM - StreetInsider Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on JAVELIN Ovarian 100 Trial of Avelumab in Previously Untreated Advanced Ovarian Cancer December 21, 2018 2:00 PM - PR NewsWire Form 8-K PFIZER INC For: Dec 19 December 21, 2018 11:04 AM - SEC Filing Pfizer (PFE) Phase 2b STRIVE Clinical Trial of Staphylococcus aureus Vaccine Discontinued Due to Futility December 20, 2018 4:31 PM - StreetInsider Independent Data Monitoring Committee Recommends Discontinuation of the Phase 2b STRIVE Clinical Trial of Staphylococcus aureus Vaccine Following Planned Interim Analysis December 20, 2018 4:30 PM - BizWire Transgene Completes Safety and Tolerability Assessment of TG4001 in Combination with Avelumab in Phase 1b Part of Trial in HPV-Positive Cancer Patients December 20, 2018 11:45 AM - BizWire Pfizer (PFE), Astellas Pharma Inc. Reports Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI (enzalutamide) in Men with Metastatic Hormone-Sensitive Prostate Cancer December 20, 2018 9:06 AM - StreetInsider Astellas and Pfizer Announce Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI® (enzalutamide) in Men with Metastatic Hormone-Sensitive Prostate Cancer December 20, 2018 9:00 AM - BizWire Astellas and Pfizer Announce Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI® (enzalutamide) in Men with Metastatic Hormone-Sensitive Prostate Cancer December 20, 2018 9:00 AM - PR NewsWire Pre-Open Stock Movers 12/19: (ADRO) (CIVI) (JBL) Higher; (SURF) (GSAT) (MU) (FDX) Lower (more...) December 19, 2018 9:27 AM - StreetInsider Form 8-K PFIZER INC For: Dec 19 December 19, 2018 9:00 AM - SEC Filing GlaxoSmithKline (GSK) Pfizer (PFE) Joint Venture Details - Morgan Stanley December 19, 2018 8:51 AM - StreetInsider Pfizer (PFE), GlaxoSmithKline (GSK) Enter Joint Venture Agreement to Create Premier Global Consumer Healthcare Company December 19, 2018 6:01 AM - StreetInsider Pfizer and GlaxoSmithKline Announce Joint Venture to Create a Premier Global Consumer Healthcare Company December 19, 2018 2:03 AM - BizWire Pfizer Invites Public to View and Listen to Webcast of January 29 Conference Call with Analysts December 18, 2018 10:00 AM - BizWire Form 4 PFIZER INC For: Dec 14 Filed by: ROGERS DAWN December 17, 2018 3:43 PM - SEC Filing Form 4 PFIZER INC For: Dec 14 Filed by: JOHNSON RADY A December 17, 2018 3:43 PM - SEC Filing Form 4 PFIZER INC For: Dec 14 Filed by: YOUNG JOHN D December 17, 2018 3:43 PM - SEC Filing Form 4 PFIZER INC For: Dec 14 Filed by: BOURLA ALBERT December 17, 2018 3:42 PM - SEC Filing Pfizer (PFE) Enters Strategic Research Collaboration & License Agreement with Kineta Immuno-Oncology to Develop New Cancer Immunotherapies December 17, 2018 8:08 AM - StreetInsider Kineta Enters Research Collaboration and License Agreement with Pfizer to Develop New Cancer Immunotherapies December 17, 2018 8:00 AM - PR NewsWire Pfizer (PFE) Raises Quarterly Dividend 5.9% to $0.36, 3.3% Yield; Authorizes New $10B Buyback December 14, 2018 12:11 PM - StreetInsider Pfizer Declares First-Quarter 2019 Dividend December 14, 2018 12:10 PM - BizWire Pfizer (PFE) Receives Positive CHMP Opinion for Oncology Biosimilar, ZIRABEV December 14, 2018 10:29 AM - StreetInsider Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, ZIRABEV™ (bevacizumab) December 14, 2018 10:29 AM - BizWire Pfizer (PFE) Commences Phase 3 Program for 20-Valent Pneumococcal Conjugate Vaccine (20vPnC) Candidate, PF-06482077 December 14, 2018 8:01 AM - StreetInsider Pfizer Initiates Phase 3 Program for 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older December 14, 2018 8:00 AM - BizWire Merck bolsters animal health unit with $2.4 billion Antelliq purchase December 14, 2018 7:05 AM - StreetInsider BMO Capital Reiterates Market Perform on Pfizer (PFE) Following Investor Meetings December 13, 2018 7:34 AM - StreetInsider JPMorgan Downgrades Pfizer (PFE) to Neutral December 11, 2018 5:05 AM - StreetInsider Exclusive: Activist investor Elliott has stake in Germany's Bayer - sources December 7, 2018 11:22 AM - StreetInsider Form 8-K PFIZER INC For: Dec 07 December 7, 2018 6:46 AM - SEC Filing Form 4 PFIZER INC For: Nov 30 Filed by: YOUNG JOHN D December 4, 2018 7:15 AM - SEC Filing Form 4 PFIZER INC For: Nov 30 Filed by: ROGERS DAWN December 4, 2018 7:15 AM - SEC Filing Form 4 PFIZER INC For: Nov 30 Filed by: JOHNSON RADY A December 4, 2018 7:15 AM - SEC Filing Form 4 PFIZER INC For: Nov 30 Filed by: BOURLA ALBERT December 4, 2018 7:15 AM - SEC Filing Pfizer Presents Positive 26-Week Data For PF-05280586, A Potential Biosimilar To Rituximab, At The American Society Of Hematology Annual Meeting December 2, 2018 3:45 PM - BizWire Pfizer (PFE) call put ratio 7.8 calls to 1 put with focus on January 46 and 48 calls November 30, 2018 12:39 PM - StreetInsider Pfizer (PFE) Reaches Global Agreement with AbbVie (ABBV) on Adalimumab Biosimilar November 30, 2018 10:01 AM - StreetInsider Pfizer Reaches a Global Agreement with AbbVie November 30, 2018 10:00 AM - BizWire Bayer to sell businesses, cut jobs after Monsanto deal November 29, 2018 9:06 AM - StreetInsider Pfizer (PFE) Granted Six Months Pediatric Exclusivity for LYRICA November 27, 2018 3:02 PM - StreetInsider Pfizer Receives Six Months Pediatric Exclusivity for LYRICA® (pregabalin) November 27, 2018 3:01 PM - BizWire Aileron Therapeutics (ALRN) Announces Clinical Trial Collaboration with Pfizer (PFE) to Evaluate ALRN-6924 in Combination with IBRANCE (palbociclib) in MDM2-Amplified Cancers November 27, 2018 8:05 AM - StreetInsider Full Article List